Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rafat Jafri"'
Autor:
Amani Al-Kofide, Hind M Alkatan, Yasser Khafaga, Khawar Siddiqui, Rafat Jafri, Mouhab Ayas, Saleh A AlMesfer
Publikováno v:
Journal of Nature and Science of Medicine, Vol 4, Iss 1, Pp 40-45 (2021)
Background: The aim is to assess if International Classification for Retinoblastoma (ICRB) and American Joint Committee on Cancer Staging System (AJCC) for patients with advanced Retinoblastoma (RB) who underwent enucleation correlated in predicting
Externí odkaz:
https://doaj.org/article/a3fb062db73e48219cc7e97f5f25a220
Autor:
Antonette Tariga Amao, Mahasen Saleh, Mouhab Ayas, Rafat Jafri, Seham Alqahtani, Ahmed AlAseri, Mohammed Sahabi, Muhammad Zulfiqar, Amani AlKofide, Saadiya Khan, Ali AlAhmari, Abdullah AlJefri, Hawazen Saleh Alsaedi, Awatif Alanazi, Ibrahim Ghemlas, Donya Qattan, Khaldoun AlShorman, Laila Ramadan, Viqaruddin Mohammed
Publikováno v:
Transplantation and Cellular Therapy. 29:S436
Autor:
Abdullah Al-Jefri, Hawazen Al-Saedi, Awatif Alanazi, Amal Al-Seraihi, Rafat Jafri, Mouhab Ayas, Mohamad Fekredeen Ayas, Ali Al-Ahmari, Ibrahim Ghemlas, Khawar Siddiqui
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2217-2221
Allogeneic hematopoietic cell transplantation (HCT) has been shown to restore normal hematopoiesis in patients with Fanconi anemia (FA), with excellent results in matched related donor HCT. Outcomes of alternative donor HCT are less favorable, howeve
Autor:
Suleimman A. Al-Sweedan, Ghaida Aljamal, Rafat Jafri, Amal Al-Seraihy, Mona Alassiri, Khawar Siddiqui
Publikováno v:
Acta Haematologica Polonica. 50:25-31
In MDS, the bone marrow produces abnormal, immature blood cells called blast cells. Imprecise, in half of pediatric MDS, blast count is normal. A retrospective observational study was conducted to review the outcome of our HCT in pediatric patients w
Autor:
Abdullah Al-Jefri, Febe Lacson, Rafat Jafri, Mouhab Ayas, Ali Al-Ahmari, Viqaruddin Mohammed, Ibrahim Ghemlas, Amal Al-Seraihy, Awatif Alanazi, Hawazen Saleh Alsaedi, Nader AlMeshari, Khaled AlNafee
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S200-S201
Introduction Hematopoietic Stem Cell Transplantation (HSCT) recipients are at an increased risk of infections including but not limited to Hospital-acquired infections (HAIs), extrinsic factors such as health-care workers and visitors plays a vital r
Autor:
Mouhab Ayas, Hind M. Alkatan, Rafat Jafri, Khawar Siddiqui, Saleh Al-Mesfer, Yasser Khafaga, Amani Al-Kofide
Publikováno v:
Journal of Nature and Science of Medicine, Vol 4, Iss 1, Pp 40-45 (2021)
Background: The aim is to assess if International Classification for Retinoblastoma (ICRB) and American Joint Committee on Cancer Staging System (AJCC) for patients with advanced Retinoblastoma (RB) who underwent enucleation correlated in predicting
Autor:
Hamoud AlMusa, Reem Mohammed, Abdullah Al-Jefri, Khawar Siddiqui, Mouhab Ayas, Ali Al-Ahmari, Rand Arnaout, Amal Al-Seraihy, Rafat Jafri, Bandar Al-Saud, Hasan Al-Dhekri, Ibrahim Ghemlas, Hawazen Saleh Alsaedi
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S216
Introduction Hematopoietic Stem Cell Transplantation (HCT) is considered the curative treatment for patients with Primary Immune Deficiencies (PIDs). Finding a full matched Human leukocyte donor remains an obstacle for performing the bone marrow tran
Publikováno v:
Journal of Blood Disorders and Medicine. 3
Autor:
Suleimman A. Al-Sweedan, Mouhab Ayas, Amal Al-Seraihy, Ali Al-Ahmari, Rafat Jafri, Khawar Siddiqui
Publikováno v:
Journal of Blood & Lymph.
Medical records of 73 patients with AML who underwent HCT, 2005-2011. The OS was 51.8% and the EFS were 48%. Median follow-up time for the cohort was 50.667 ± 2.4 months (95%CI: 45.9-55.4). 39 patients were alive with a median follow-up time of 50.1
Autor:
Suleimman A. Al-Sweedan, Abdullah Al-Jefri, Khawar Siddiqui, Mouhab Ayas, Ali Al-Ahmari, Viqaruddin Mohammed, Amal Al-Seraihy, Rafat Jafri
Publikováno v:
Journal of pediatric hematology/oncology. 39(1)
Medical records of 82 patients with acute lymphoblastic leukemia (ALL) who underwent hematopoietic cell transplantation (HCT) at our institution from 2005 to 2011 were reviewed. Forty-five patients were male (54.8%). The median age at HCT was 7.46 ye